Karol Kaiser

Dr. Karol Kaiser

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
VPVendula Pospichalova
Vendula Pospichalova
JSJan Svoboda
Jan Svoboda
ZDZankruti Dave
Zankruti Dave
AKAnna Kotrbova
Anna Kotrbova
KKKarol Kaiser
Karol Kaiser
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
Flow cytometry is a powerful method, which is widely used for high‐throughput quantitative and qualitative analysis of cells. However, its straightforward applicability for extracellular vesicles (EVs) and mainly exosomes is hampered by several challenges, reflecting mostly the small size of these vesicles (exosomes: ~80–200 nm, microvesicles: ~200–1,000 nm), their polydispersity, and low refractive index. The current best and most widely used protocol for beads‐free flow cytometry of exosomes uses ultracentrifugation (UC) coupled with floatation in sucrose gradient for their isolation, labeling with lipophilic dye PKH67 and antibodies, and an optimized version of commercial high‐end cytometer for analysis. However, this approach requires an experienced flow cytometer operator capable of manual hardware adjustments and calibration of the cytometer. Here, we provide a novel and fast approach for quantification and characterization of both exosomes and microvesicles isolated from cell culture media as well as from more complex human samples (ascites of ovarian cancer patients) suitable for multiuser labs by using a flow cytometer especially designed for small particles, which can be used without adjustments prior to data acquisition. EVs can be fluorescently labeled with protein‐(Carboxyfluoresceinsuccinimidyl ester, CFSE) and/or lipid‐ (FM) specific dyes, without the necessity of removing the unbound fluorescent dye by UC, which further facilitates and speeds up the characterization of microvesicles and exosomes using flow cytometry. In addition, double labeling with protein‐ and lipid‐specific dyes enables separation of EVs from common contaminants of EV preparations, such as protein aggregates or micelles formed by unbound lipophilic styryl dyes, thus not leading to overestimation of EV numbers. Moreover, our protocol is compatible with antibody labeling using fluorescently conjugated primary antibodies. The presented methodology opens the possibility for routine quantification and characterization of EVs from various sources. Finally, it has the potential to bring a desired level of control into routine experiments and non‐specialized labs, thanks to its simple bead‐based standardization.

2 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKarol Kaiser
Karol Kaiser
DGDaniel Gyllborg
Daniel Gyllborg
JPJan Procházka
Jan Procházka
ASAlena Salašová
Alena Salašová
PKPetra Kompaníková
Petra Kompaníková
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
WNTs are lipid-modified proteins that control multiple functions in development and disease via short- and long-range signaling. However, it is unclear how these hydrophobic molecules spread over long distances in the mammalian brain. Here we show that WNT5A is produced by the choroid plexus (ChP) of the developing hindbrain, but not the telencephalon, in both mouse and human. Since the ChP produces and secretes the cerebrospinal fluid (CSF), we examine the presence of WNT5A in the CSF and find that it is associated with lipoprotein particles rather than exosomes. Moreover, since the CSF flows along the apical surface of hindbrain progenitors not expressing Wnt5a, we examined whether deletion of Wnt5a in the ChP controls their function and find that cerebellar morphogenesis is impaired. Our study thus identifies the CSF as a route and lipoprotein particles as a vehicle for long-range transport of biologically active WNT in the central nervous system.

27 October 2021 in eLife
Verified
Journal Article
Open access
TRTomasz Radaszkiewicz
Tomasz Radaszkiewicz
MNMichaela Nosková
Michaela Nosková
KGKristína Gömöryová
Kristína Gömöryová
OBOlga Vondálová Blanářová
Olga Vondálová Blanářová
KRKatarzyna Anna Radaszkiewicz
Katarzyna Anna Radaszkiewicz
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
RNF43 is an E3 ubiquitin ligase and known negative regulator of WNT/β-catenin signaling. We demonstrate that RNF43 is also a regulator of noncanonical WNT5A-induced signaling in human cells. Analysis of the RNF43 interactome using BioID and immunoprecipitation showed that RNF43 can interact with the core receptor complex components dedicated to the noncanonical Wnt pathway such as ROR1, ROR2, VANGL1, and VANGL2. RNF43 triggers VANGL2 ubiquitination and proteasomal degradation and clathrin-dependent internalization of ROR1 receptor and inhibits ROR2 activation. These activities of RNF43 are physiologically relevant and block pro-metastatic WNT5A signaling in melanoma. RNF43 inhibits responses to WNT5A, which results in the suppression of invasive properties of melanoma cells. Furthermore, RNF43 prevented WNT5A-assisted development of resistance to BRAF V600E and MEK inhibitors. Next, RNF43 acted as melanoma suppressor and improved response to targeted therapies in vivo. In line with these findings, RNF43 expression decreases during melanoma progression and RNF43-low patients have a worse prognosis. We conclude that RNF43 is a newly discovered negative regulator of WNT5A-mediated biological responses that desensitizes cells to WNT5A.

Verified
Journal Article
Open access
PDF file
KKKarol Kaiser
Karol Kaiser
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
Cerebrospinal fluid (CSF) is the liquid that fills the brain ventricles. CSF represents not only a mechanical brain protection but also a rich source of signalling factors modulating diverse processes during brain development and adulthood. The choroid plexus (CP) is a major source of CSF and as such it has recently emerged as an important mediator of extracellular signalling within the brain. Growing interest in the CP revealed its capacity to release a broad variety of bioactive molecules that, via CSF, regulate processes across the whole central nervous system (CNS). Moreover, CP has been also recognized as a sensor, responding to altered composition of CSF associated with changes in the patterns of CNS activity. In this review, we summarize the recent advances in our understanding of the CP as a signalling centre that mediates long-range communication in the CNS. By providing a detailed account of the CP secretory repertoire, we describe how the CP contributes to the regulation of the extracellular environment—in the context of both the embryonal as well as the adult CNS. We highlight the role of the CP as an important regulator of CNS function that acts via CSF-mediated signalling. Further studies of CP–CSF signalling hold the potential to provide key insights into the biology of the CNS, with implications for better understanding and treatment of neuropathological conditions.

25 May 2021 in Development
Verified
Journal Article
Open access
PDF file
KKKarol Kaiser
Karol Kaiser
AJAhram Jang
Ahram Jang
PKPetra Kompanikova
Petra Kompanikova
MLMelody P. Lun
Melody P. Lun
JPJan Prochazka
Jan Prochazka
Vítězslav BryjaVítězslav Bryja
Vítězslav Bryja
The choroid plexus (ChP) produces cerebrospinal fluid and forms an essential brain barrier. ChP tissues form in each brain ventricle, each one adopting a distinct shape, but remarkably little is known about the mechanisms underlying ChP development. Here, we show that epithelial WNT5A is crucial for determining fourth ventricle (4V) ChP morphogenesis and size in mouse. Systemic Wnt5a knockout, or forced Wnt5a overexpression beginning at embryonic day 10.5, profoundly reduced ChP size and development. However, Wnt5a expression was enriched in Foxj1-positive epithelial cells of 4V ChP plexus, and its conditional deletion in these cells affected the branched, villous morphology of the 4V ChP. We found that WNT5A was enriched in epithelial cells localized to the distal tips of 4V ChP villi, where WNT5A acted locally to activate non-canonical WNT signaling via ROR1 and ROR2 receptors. During 4V ChP development, MEIS1 bound to the proximal Wnt5a promoter, and gain- and loss-of-function approaches demonstrated that MEIS1 regulated Wnt5a expression. Collectively, our findings demonstrate a dual function of WNT5A in ChP development and identify MEIS transcription factors as upstream regulators of Wnt5a in the 4V ChP epithelium.

19 August 2025 in bioRxiv
Verified
Preprint
Open access
KKKarol Kaiser
Karol Kaiser
VSVioleta Silva-Vargas
Violeta Silva-Vargas
LALuca von Allmen
Luca von Allmen
TSThomas Sakoparnig
Thomas Sakoparnig
FDFiona Doetsch
Fiona Doetsch
The choroid plexus (ChP)-cerebrospinal fluid (CSF) axis is emerging as a key regulator of the brain environment. The ChP is a multi-functional structure, which forms the blood-CSF barrier, and acts as a sensor of inputs from the periphery and the brain, dynamically responding by modulating its secretome into the CSF. However, sex differences in the ChP have been little explored. Molecular profiling of the adult mouse ChP at the transcriptomic and proteomic levels revealed sex differences across multiple cell types, with immune signatures enriched in females. Interestingly, border associated macrophages showed distinct sex differences in the stromal and epiplexus compartments. We further uncovered sex differences in ChP secretory signalling, with functional differences between males and females. Finally, the human LVChP showed largely similar sex differences. Together, our findings highlight that sex differences may play an important role in ChP function in both health and disease.